Fatty acid mitochondrial β-oxidation and hypoglycaemia in children

Current Opinion in Neurology

Volumn 9, Issue 6, 1996, Pages 477-485

  Taroni, Franco ^a   Uziel, Graziella ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID;

CHILD; DIET RESTRICTION; ENERGY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENETIC DISORDER; HUMAN; HYPOGLYCEMIA; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; MYOPATHY; REVIEW; STRESS; SUDDEN DEATH;

EID: 0030469997     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199612000-00015     Document Type: Review

References (88)

1. McCall AL: Effects of glucose deprivation on glucose metabolism in the central nervous system. In Hypoglycaemia and diabetes: clinical and physiological aspects. Edited by Frier BM, Fisher BM. London: Edward Arnold; 1993:56-71.
2. Service FJ: Hypoglycemic disorders. N Engl J Med 1995, 332:1144-1152.
3. Bennett MJ: The enzymes of mitochondrial fatty acid oxidation. Clin Chim Acta 1994, 226:211-224.
4. Pons R, DeVivo DC: Primary and secondary carnitine deficiency syndromes. J Child Neurol 1995, 10:2S8-2S24.
5. Roe CR, Coates PM: Mitochondrial fatty acid oxidation disorders. In The metabolic and molecular bases of inherited disease, edn 7. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill; 1995:1501-1533. An authoritative and comprehensive review of the metabolic basis and clinical findings of fatty acid oxidation defects. The authors include a thorough evaluation of the diagnostic approach to patients with suspected β-oxidation disorders.
6. Stanley C: Carnitine disorders. Adv Pediatr 1995, 42:209-242.
7. Guzmán M, Geelen MJH: Regulation of fatty acid oxidation in mammalian liver. Biochim Biophys Acta 1993, 1167:227-241.
8. Pande SV, Murthy MS: Carnitine-acylcarnitine translocase deficiency: implications in human pathology. Biochim Biophys Acta 1994, 1226:269-276.
9. Kunau WH, Dommes V, Schulz H: Beta oxidation of fatty acids in mitochondria, peroxisomes and bacteria. A century of continued progress. Prog Lipid Res 1996 (In press).
10. Jackson S, Schaefer J, Middleton B, Turnbull DM: Characterisation of a novel enzyme of human fatty acid beta-oxidation: a matrix-associated, mitochondrial 2-enoyl-CoA hydratase. Biochem Biophys Res Commun 1995, 214:247-53.
11. Schulz H: Mitochondrial β-oxidation. In Fatty acid oxidation: clinical, biochemical, and molecular aspects. Edited by Tanaka K, Coales PM. New York: Alan R. Liss; 1990:23-36.
12. Izai K, Uchida Y, Orii T, Yamamoto S, Hashimoto T: Novel fatty acid β-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long chain acyl-coenzyme A dehydrogenase. J Biol Chem 1992, 267:1027-1033.
13. Uchida Y, Izai K, Orii T, Hashimoto T: Novel fatty acid β-oxidation enzymes in rat liver mitochondria. II. Purification and properties of enoyl-coenzyme A (CoA) hydratase/3-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein. J Biol Chem 1992, 267:1034-1041.
14. 4]linoleate and L-carnitine and analysing the resultant labeled acylcarnitines by tandem mass spectrometry.
15. Sumegi B, Porpaczy Z, Alkonyi I: Kinetic advantage of the interaction between the fatty acid beta-oxidation enzymes and the complexes of the respiratory chain. Biochim Biophys Acta 1991, 1081:121-128.
16. Taroni F: Carnitine palmitoyltransferase deficiency. In Neurobase, (CD-ROM) edn 1. Edited by Gilman S, Goldstein GW, Waxman SG. La Jolla: Arbor Publishing; 1995. An exhaustive review of the clinical, biochemical and molecular aspects of defects of the mitochondrial carnitine palmitoyltransferases.
17. Aoyama T, Souri M, Ushikubo S, Kamijo T, Yamaguchi S, Kelley RI, Rhead WJ, Uetake K, Tanaka K, Hashimoto T: Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients. J Clin Invest 1995, 95:2465-2473.
18. Pons R, Roig M, Riudor E, Ribes A, Briones P, Ortigosa L, Baldellou A, Gil-Gibernau J, Olesti M, Navarro C, Wanders RJA: The clinical spectrum of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Neurol 1996, 14:236-243. Interesting paper that presents the clinical and biochemical findings in four original LCHAD-deficient patients along with a detailed review of patients with LCHAD deficiency reported in the literature.
19. Kamijo T, Wanders RJA, Saudubray J-M, Aoyama T, Komiyama A, Hashimoto T: Mitochondrial trifunctional protein deficiency. Catalytic heterogeneity of the mutant enzyme in two patients. J Clin Invest 1994, 93:1740-1747.
20. Bhala A, Willi SM, Rinaldo P, Bennett MJ, Schmidt Sommerfeld E, Hale DE: Clinical and biochemical characterization of short-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr 1995, 126:910-915.
21. Bennett MJ, Weinberger MJ, Kobori JA, Rinaldo P, Burlina AB: Mitochondrial short-chain i-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: a new defect of fatty acid oxidation. Pediatr Res 1996, 39:185-188. First documented cases of short-chain L-3-hydroxyacyl-CoA deficiency. Demonstration of the enzyme defect in fibroblasts from two children presenting with fasting-induced vomiting and ketosis, with or without hypoglycaemia.
22. Loehr JP, Goodman SI, Frerman FE: Glutaric acidemia type II: heterogeneity of clinical and biochemical phenotypes. Pediatr Res 1990, 27:311-315.
23. Antozzi C, Garavaglia B, Mora M, Rimoldi M, Morandi L, Ursino E, DiDonato S: Late-onset riboflavin-responsive myopathy with combined multiple acyl coenzyme A dehydrogenase and respiratory chain deficiency. Neurology 1994, 44:2153-2158.
24. McKusick VA: Mendelian inheritance in man, edn 11. Baltimore: Johns Hopkins University Press; 1994.
25. Stanley CA, Hale DE. Genetic disorders of mitochondrial fatty acid oxidation. Curr Opin Pediatr 1994, 6:476-481.
26. Parini R, Garavaglia B, Saudubray JM, Bardelli P, Melotti D, Zecca G, DiDonato S: Clinical diagnosis of long-chain acyl-coenzyme A-dehydrogenase deficiency: use of stress and fat-loading tests. J Pediatr 1991, 119:77-80.
27. Saudubray J-M, Mitchell G, Bonnefont J-P, Schwatz G, Nuttin C, Munnich A, Brivet M, Vassault A, Demaugre F, Rabier D, Charpentier C: Approach to the patient with a fatty acid oxidation disorder. In New developments in fatty acid oxidation. Edited by Coates PM, Tanaka K. New York: Wiley-Liss; 1992:271-288.
28. González-Manchón C, Martín-Requero A, Ayuso M, Parrilla R: Role of endogenous fatty acids in the control of hepatic gluconeogenesis. Arch Biochem Biophys 1992, 292:95-101.
29. Kelly DP, Strauss AW: Inherited cardiomyopathies. N Engl J Med 1994, 330:913-919.
30. Oliver MF, Opie LH: Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994, 343:155-158.
31. Treem WR, Rinaldo P, Hale DE, Stanley CA, Millington DS, Hyams JS, Jackson S, Turnbull DM: Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology 1994, 19:339-45.
32. •].
33. •] that present in-vitro evidence of a toxic effect of long-chain acyl-CoA esters on mitochondrial oxidative phosphorylation. The results provide a biochemical rationale for the occurrence of lactic acidemia in some disorders of long-chain fatty acid oxidation.
34. Rabier D, Bardet J, Parvy P, Poggi F, Brivet M, Saudubray JM, Kamoun P: Do criteria exist from urinary organic acids to distinguish β-oxidation defects? J Inherit Metab Dis 1995, 18:257-260.
35. Pourfarzam M, Schaefer J, Turnbull DM, Bartlett K: Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders. Clin Chem 1994, 40:2267-2275.
36. Schaefer J, Jackson S, Taroni F, Swift P, Turnbull DM: Characterisation of cellular carnitine acyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy. J Neurol Neurosurg Psychiatry 1996 (In press).
37. 14C]hexadecanoate, β-oxidation flux and acylcarnitine esters formed were measured, demonstrating a characteristic accumulation of acylcarnitines that was pathognomonic for the site of the defect.
38. Rashed MS, Ozand PT, Bennert MJ, Barnard JJ, Govindaraju DR, Rinaldo P: Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile. Clin Chem 1995, 41:1109-1114.
39. McGarry JD: The mitochondrial carnitine palmitoyltransferase system: its broadening role in fuel homeostasis and new insights into its molecular features. Biochem Soc Trans 1995, 23:321-324.
40. Finocchiaro G, Taroni F, Rocchi M, Liras Martin A, Colombo I, Torri Tarelli G, DiDonato S: cDNA cloning, sequence analysis and chromosomal localization of human carnitine palmitoyltransferase. Proc Natl Acad Sci U S A 1991, 88:661-665.
41. Britton CH, Schultz RA, Zhang B, Esser V, Foster DW, McGarry JD: Human liver carnitine palmitoyltransferase I: characterization of its cDNA and chromosomal localization and partial analysis of the gene. Proc Natl Acad Sci U S A 1995, 92:1984-1988.
42. Gellera C, Verderio E, Floridia G, Finocchiaro G, Montermini L, Cavadini P, Zuffardi O, Taroni F: Assignment of the human carnitine palmitoyltransferase II gene (CPT1) to chromosome 1p32. Genomes 1994, 24:195-197.
43. 1? J Neurol Sci 1989, 92:229-245.
44. McGarry J: Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership. Biochem Soc Trans 1995, 23:481-485. A concise review of the current concepts on the carnitine palmitoyltransferase system, mostly based on the author's seminal work on the subject.
45. Tonin P, Lewis P, Servidei S, DiMauro S: Metabolic causes of myoglobinuria. Ann Neurol 1990, 27:181-185.
46. Demaugre F, Bonnefont J-P, Colonna M, Cepanec C, Leroux J-P, Saudubray JM: Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies. J Clin Invest 1991, 87:859-864.
47. Hug G, Bove KE, Soukup S: Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II. N Engl J Med 1991, 325:1862-1864.
48. Taroni F, Verderio E, Garavaglia B, Fiorucci S, Finocchiaro G, Uziel G, DiDonato S: Biochemical and molecular studies of carnitine palmitoyltransferase II deficiency with hepatocardiomyopathic presentation. In New developments in fatty acid oxidation. Edited by Coates PM, Tanaka K. New York: Wiley-Liss; 1992:521-531.
49. Taroni F, Verderio E, Dworzak F, Willems PJ, Cavadini P, DiDonato S: Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients. Nature Genet 1993, 4:314-320.
50. Witt DR, Theobald M, Santa-Maria M, Packman S, Townsend S, Sweetman L, Goodman S, Rhead W, Hoppel C: Carnitine palmitoyl transferase-type 2 deficiency: two new cases and successful prenatal diagnosis [Abstract]. Am J Hum Genet 1991, 49:A109.
51. North KN, Hoppel CL, DeGirolami U, Kozakewich HPW, Korson MS: Lethal neonatal deficiency carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys. J Pediatr 1995, 127:414-420. An interesting paper that reports the clinicopathologic findings in a patient with the recently recognized neonatal-onset form of CPT-II deficiency. Differential diagnosis with other metabolic defects associated with congenital anomalies of brain and kidney is discussed.
52. Taroni F, Gellera C, Cavadini P, Baratta S, Lamantea E, Dethlefs S, DiDonato S, Reik RA, Benke PJ: Lethal carnitine palmitoyltransferase (CPT) II deficiency in newborns: a molecular genetic study [Abstract]. Am J Hum Genet 1994, 55:A245.
53. Land JM, Mistry S, Squier M, Hope P, Ghadiminejad I, Orford M, Saggerson D: Neonatal carnitine palmitoyltransferase-2 deficiency: a case presenting with myopathy. Neuromus Disord 1995, 5:129-137.
54. Shintani S, Shiigai T, Sugiyama N: Atypical presentation of carnitine palmitoyltransferase (CPT) deficiency as status epilepticus. J Neurol Sci 1995, 129:69-73.
55. Bonnefont J-P, Taroni F, Cavadini P, Cepanec C, Brivet M, Saudubray J-M, Leroux J-P, Demaugre F: Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression. Am J Hum Genet 1996, 58:971-978. An interesting report of a second CPT-II mutation causing the hepatocardiomuscular form of the disease. The functional consequences of the mutation were investigated in transfected COS cells. Evidence is presented that a correlation exists between residual LCFA oxidation rates and phenotypic presentation and that CPT-II activity has to be reduced below a critical threshold in order for LCFA oxidation to be impaired.
56. Handig I, Dams E, Taroni F, van Laere S, de Barsy T, Willems PJ: Inheritance of the S113L mutation within an inbred family with carnitine palmitoyltransferase enzyme deficiency. Hum Genet 1996, 97:291-293.
57. Verderio E, Cavadini P, Montermini L, Wang H, Lamantea E, Finocchiaro G, Di Donato S, Gellera C, Taroni F: Carnitine palmitoyltransferase II deficiency: structure of the gene and characterization of two novel disease-causing mutations. Hum Mol Genet 1995, 4:19-29.
58. Taroni F, Verderio E, Fiorucci S, Cavadini P, Finocchiaro G, Uziel G, Lamantea E, Gellera C, DiDonato S: Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. Proc Natl Acad Sci U S A 1992, 89:8429-8433.
59. Yamamoto S, Abe H, Kohgo T, Ogawa A, Ohtake A, Hayashibe H, Sakuraba H, Suzuki Y, Aramaki S, Takayanagi M et al.: Two novel gene mutations (Glu174→Lys, Phe383→Tyr) causing the 'hepatic' form of carnitine palmitoyltransferase II deficiency. Hum Genet 1996, 98:116-118.
60. Gellera C, Witt DR, Verderio E, Cavadini P, DiDonato S, Taroni F: Molecular study of lethal neonatal carnitine palmitoyltransferase II (CPT II) deficiency [Abstract]. Am J Hum Genet 1992, 51:A168.
61. Hale DE, Batshaw M, Coates PM, Frerman FE, Goodman SI, Singh I, Stanley CA: Long-chain acyl-coenzyme A dehydrogenase deficiency: an inherited cause of non-ketotic hypoglycemia. Pediatr Res 1985, 19:666-671.
62. Yamaguchi S, Indo Y, Coates PM, Hashimoto T, Tanaka K: Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 1993, 34:111-113.
63. Bertrand C, Largillière C, Zabot MT, Mathieu M, Vianey-Saban C: Very long chain acyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid oxidation in fibroblasts. Biochim Biophys Acta 1993, 1180:327-329.
64. •].
65. •].
66. •].
67. •] on the molecular genetics of VLCAD deficiency. The authors report the sequence of human VLCAD cDNA and chromosomal localization of the gene along with identification of the first disease causing mutations in patients with VLCAD deficiency.
68. Andresen BS, Vianey-Saban C, Bross P, Divry P, Roe CR, Nada MA, Knudsen I, Gregersen N: The mutational spectrum in very-long-chain acyl-CoA dehydrogenase deficiency. J Inher Metab Dis 1996, 19:169-172.
69. Merinero B, Pérez-Cerdà C, Garcia Silva MT, Vianey-Saban C, Duran M, Ugarte M: Mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency with a mild clinical course. J Inher Metab Dis 1996, 19:173-176.
70. Nada MA, Vianey-Saban C, Roe CR: Very-long-chain acyl-CoA dehydrogenase deficiency: two phenotypes with distinctive biochemical findings [Abstract]. J Inher Metab Dis 1996, 19(suppl 1):53.
71. Ogilvie I, Pourfarzam M, Jackson S, Stockdale C, Bartlett K, Turnbull DM: Very long-chain acyl coenzyme A dehydrogenase deficiency presenting with exercise-induced myoglobinuria. Neurology 1994, 44:467-473.
72. Gillett GT, Krywawych S, Brivet M, Vianey-Saban C, Gregersen N, Andresen BS, Brenton DP: VLCAD deficiency presenting with recurrent rhabdomyolysis in an adult [Abstract]. J Inher Metab Dis 1996, 19(suppl 1):54.
73. Ushikubo S, Aoyama T, Kamijo T, Wanders RJA, Rinaldo P, Vockley J, Hashimoto T: Molecular characterization of mitochondrial trifunctional protein deficiency: formation of the enzyme complex is important for stabilization of both α- and β-subunits. Am J Hum Genet 1996, 58:979-988. An important paper on the identification and functional characterization of MTP α-and β-subunit mutations in patients with trifunctional protein deficiency. The mutations were modeled in patients' fibroblasts using a vaccinia virus-based expression system. Evidence is provided that mutations in the β-subunit interfere with hetero-octamer assembly and result in a rapid decomposition of MTP.
74. IJlst L, Wanders RJ, Ushikubo S, Kamijo T, Hashimoto T: Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of the major disease-causing mutation in the alpha-subunit of the mitochondrial trifunctional protein. Biochim Biophys Acta 1994, 1215:347-350.
75. Dionisi-Vici C, Garavaglia B, Burlina AB, Bertini E, Saponara I, Sabetta G, Taroni F: Hypoparathyroidism in mitochondrial trifunctional protein deficiency. J Pediatr 1996, 129:159-162.
76. Hagenfeldt L, Venizelos N, von Döbeln U: Clinical and biochemical presentation of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inher Metab Dis 1995, 18:245-248.
77. Sims HF, Brackett JC, Powell CK, Treem WR, Hale DE, Bennett MJ, Gibson B, Shapiro S, Strauss AW: The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci U S A 1995, 92:841-845. An interesting paper on the identification of the common Glu510Gln mutation in the LCHAD domain of MTP α-subunit in families with children with LCHAD deficiency and mothers with the acute fatty liver of pregnancy syndrome. The pathogenic role of the mutation was demonstrated in a bacterial expression system.
78. IJlst L, Ushikubo S, Kamijo T, Hashimoto T, Ruiter JPN, de Klerk JBC, Wanders RJA: Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: high frequency of the G1528C mutation with no apparent correlation with the clinical phenotype. J Inher Metab Dis 1995, 18:241-244.
79. IJlst L, Ruiter JPN, Vreijling J, Wanders RJA: Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a new method to identify the G1528C mutation in genomic DNA showing its high frequency (≈90%) and identification of a new mutation (T2198C). J Inher Metab Dis 1996, 19:165-168.
80. Jackson S, Singh Kler R, Bartlett K, Briggs H, Bindoff LA, Pourfarzam M, Gardner-Medwin D, Turnbull DM: Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest 1992, 90:1219-1225.
81. Dionisi-Vici C, Burlina AB, Bertini E, Bachmann C, Mazziotta MRM, Zacchello F, Sabetta G, Hale DE: Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxy-acyl-coenzyme A dehydrogenase deficiency. J Pediatr 1991, 118:744-746.
82. Bertini E, Dionisi-Vici C, Garavaglia B, Burlina AB, Sabatelli M, Rimoldi M, Bartuli A, Sabetta G, DiDonato S: Peripheral sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency. Eur J Pediatr 1992, 151:121-126.
83. Tein I, Donner EJ, Hale DE, Murphy EG: Clinical and neurophysiologic response of myopathy and neuropathy in long-chain i-3-hydroxyacyl-CoA dehydrogenase deficiency to oral prednisone. Pediatr Neurol 1995, 12:68-76.
84. Brackett JC, Sims HF, Rinaldo P, Shapiro S, Powell CK, Bennett MJ, Strauss AW: Two α-subunit donor splice site mutations cause human trifunctional protein deficiency. J Clin Invest 1995, 95:2076-2082.
85. Orii KE, Aoyama T, Souri M, Jiang LL, Orii KO, Hayashi S, Yamaguchi S, Kondo N, Orii T, Hashimoto T: Formation of the enzyme complex is required for function of trifunctional β-oxidation protein. Biochem Biophys Res Comm 1996, 219:773-777.
86. Ruitenbeek W, Poels PJ, Turnbull DM, Garavaglia B, Chalmers RA, Taylor RW, Gabreels FJ: Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency. J Neurol Neurosurg Psychiatry 1995, 58:209-214.
87. Christodoulou J, Hoare J, Hammond J, Ip WC, Wilcken B: Neonatal onset of medium-chain acyl-coenzyme A dehydrogenase deficiency with confusing biochemical features. J Pediatr 1995, 126:65-68.
88. Corydon MJ, Gregersen N, Lehnert W, Ribes A, Rinaldo P, Kmoch S, Christensen E, Kristensen TJ, Andresen BS, Bross P et al.: Ethylmalonic aciduria is associated with an amino acid variant of short chain acylcoenzyme A dehydrogenase. Pediatr Res 1996, 39:1059-1066.